This looks like it could repeat ADO to me, purely looking at market cap and projected sales - both short term in the UK and in targetted global markets.
I did some rough dirty numbers. UK market best possible percentage is 1.2% of total population (includes men - these are dirty fast numbers). So then I worked out global market could be around 25M women,
Working: Europe (100% affordable) Asia (25% affordable) South America (50% affordable) North America (100% affordable)
I got close to a total of 1.8bn people (men and women). So take the UK percentage of possible tests at 1.2% total population, that's 21.6 million tests a year, times $70.
These rough estimates are all prob way too high... but still that sales of 1.5Bn. I think TwinTurboCelica is closer to the real potential number.
I bought up very big this morning.
HTX Price at posting:
11.5¢ Sentiment: LT Buy Disclosure: Held